DTx Part I: Identifying Optimal Payment Models for Digital Therapeutics

2020-02-06T15:36:50-05:00

The field of DTx has gained traction over the last couple of years, with FDA approvals/clearances, the founding of a DTx specialty society, large-scale acquisitions of DTx firms, pharma investments in DTx, and pharma co-development deals, amongst other key developments.

DTx Part I: Identifying Optimal Payment Models for Digital Therapeutics2020-02-06T15:36:50-05:00

ICER Set to Evaluate Non-Drug Products in 2020

2020-01-14T09:19:17-05:00

The Boston-based Institute for Clinical and Economic Review (ICER) recently announced that in 2020, they are considering selecting two or more non-drug topics for assessment.

ICER Set to Evaluate Non-Drug Products in 20202020-01-14T09:19:17-05:00